ViPOR Results in Durable Remission in Specific Subtypes of Lymphoma
Complete responses seen in 38 percent of patients, all with non-GCB DLBCL, high-grade B-cell lymphoma with rearrangements of MYC and BCL2 or BCL6
Burden of Chronic Health Conditions Increased for LGTBQ+ Cancer Survivors
Highest prevalence of all outcomes seen among transgender or gender-nonconforming survivors
Black Patients More Likely to Experience MACE After ADT for Prostate Cancer
Social vulnerability index mediated 98 percent of the disparity in MACE risk between Black and White patients
Dementia With Lewy Bodies Risk Down With α-1 Adrenergic Receptor Antagonists
Risk for developing DLB was lower for men newly started on Tz/Dz/Az compared with those taking tamsulosin or 5ARI
Approximately 7 Percent of U.S. Population Uninsured in 2023
10.9 percent of adults aged 18 to 64 years were uninsured at the time of interview in 2023, as were 3.9 percent of children aged 0 to 17 years
Trametinib Safe, Effective for Juvenile Myelomonocytic Leukemia
Seven of 10 children with relapsed or refractory JMML completed all 12 cycles of therapy or used trametinib as bridge to HSCT
Pandemic-Era Tax Credits Made Healthcare More Affordable, But They’re Set to Expire
1999 to 2020 Saw Diet Quality Improve Among U.S. Adults
However, disparities in diet quality were persistent or worsened by age, sex, race and ethnicity, education, income
Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy
Lethal T-cell lymphoma identified in one patient who received axicabtagene ciloleucel therapy for diffuse large B-cell lymphoma
Neighborhood Deprivation Only Tied to Breast Cancer Mortality for White Women
Higher neighborhood deprivation ups risk of breast cancer mortality by 47 percent
